10-Q Filing

UNI-PIXEL CIK: 1171012 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001185185-14-001998`
Period End Date	20140630
Filing Date	20140807
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	unxl-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 47 Income Statement 49 Cash Flow Statement 55 Stockholders Equity 28

Balance Sheet 47 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$7.76M	USD	Point-in-time
Accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$4.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$30.36M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$39.37M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$53.41M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Account receivable, net	`AccountsReceivableNetCurrent`	$11.41K	USD	Point-in-time
Account receivable, net	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.35M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$142.50K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.24M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.24M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$39.38M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$30.50M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.35M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $7,755,099 and $4,769,453, at June 30, 2014 and December 31, 2013, respectively	`PropertyPlantAndEquipmentNet`	$13.89M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $7,755,099 and $4,769,453, at June 30, 2014 and December 31, 2013, respectively	`PropertyPlantAndEquipmentNet`	$15.89M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$17.44K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$17.44K	USD	Point-in-time
Total assets	`Assets`	$44.41M	USD	Point-in-time
Total assets	`Assets`	$55.29M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.05M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$606.25K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$5.00M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$5.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.61M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.05M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.61M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.05M	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 3)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 12,349,047 shares issued and outstanding at June 30, 2014 and 12,244,714 shares issued and outstanding at December 31, 2013	`CommonStockValue`	$12.35K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized, 12,349,047 shares issued and outstanding at June 30, 2014 and 12,244,714 shares issued and outstanding at December 31, 2013	`CommonStockValue`	$12.24K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$135.72M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$137.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-98.75M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-86.49M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$49.24M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$38.80M	USD	Point-in-time
Total shareholders equity	`StockholdersEquity`	$14.37M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$55.29M	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$44.41M	USD	Point-in-time

Income Statement 49 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	-	USD	2 Qtrs
Revenue	`SalesRevenueNet`	$5.07M	USD	2 Qtrs
Revenue	`SalesRevenueNet`	$749.00	USD	1 Quarter
Revenue	`SalesRevenueNet`	-	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$3.42K	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	-	USD	2 Qtrs
Cost of revenues	`CostOfRevenue`	-	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$385.00	USD	1 Quarter
Gross margin	`GrossProfit`	-	USD	1 Quarter
Gross margin	`GrossProfit`	$5.07M	USD	2 Qtrs
Gross margin	`GrossProfit`	$364.00	USD	1 Quarter
Gross margin	`GrossProfit`	-	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.08M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.17M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$4.35M	USD	2 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$5.95M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.53M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.99M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$6.32M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.47M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-12.26M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.75M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.07M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.70M	USD	1 Quarter
Interest income (expense), net	`InterestExpense`	$-6.47K	USD	2 Qtrs
Interest income (expense), net	`InterestExpense`	$-8.87K	USD	2 Qtrs
Interest income (expense), net	`InterestExpense`	$-4.07K	USD	1 Quarter
Interest income (expense), net	`InterestExpense`	$-5.48K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.75M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.18M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.70M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.25M	USD	2 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.35	USD	2 Qtrs
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.40	USD	1 Quarter
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.49	USD	1 Quarter
Net loss - basic (in Dollars per share)	`EarningsPerShareBasic`	$-1.00	USD	2 Qtrs
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.35	USD	2 Qtrs
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.49	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.40	USD	1 Quarter
Net loss - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.00	USD	2 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	11.63M	shares	1 Quarter
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	10.85M	shares	2 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.31M	shares	2 Qtrs
Weighted average number of basic common shares outstanding (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	12.35M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.31M	shares	2 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.85M	shares	2 Qtrs
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	11.63M	shares	1 Quarter
Weighted average number of diluted common shares outstanding (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.35M	shares	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Issuance of Common for Cashless Exercise of Warrants	`StockIssuedDuringPeriodSharesOther`	64,699.00	shares	2 Qtrs
Issuance of Common for Cashless Exercise of Warrants	`StockIssuedDuringPeriodSharesOther`	399,629.00	shares	2 Qtrs
Cashless Exercise of Warrants	`ClassOfWarrantOrRightsExercised`	126,433.00	shares	2 Qtrs
Cashless Exercise of Warrants	`ClassOfWarrantOrRightsExercised`	505,661.00	shares	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.75M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.18M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.70M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.25M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.99M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$539.47K	USD	2 Qtrs
Restricted stock issuance	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$763.97K	USD	2 Qtrs
Restricted stock issuance	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$514.36K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$1.27M	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$1.46M	USD	2 Qtrs
Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-11.41K	USD	2 Qtrs
Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
(Increase) decrease in prepaid assets and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-160.32K	USD	2 Qtrs
(Increase) decrease in prepaid assets and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$142.50K	USD	2 Qtrs
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$-447.50K	USD	2 Qtrs
Increase (decrease) in accounts payable	`IncreaseDecreaseInAccountsPayable`	$940.53K	USD	2 Qtrs
Increase in bonus accrual	`IncreaseDecreaseInOtherAccruedLiabilities`	$273.68K	USD	2 Qtrs
Increase in bonus accrual	`IncreaseDecreaseInOtherAccruedLiabilities`	-	USD	2 Qtrs
Increase in deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	2 Qtrs
Increase in deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$5.00M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.39M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.06M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$978.90K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.86M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.86M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-978.90K	USD	2 Qtrs
Proceeds from exercise of warrants, net	`ProceedsFromWarrantExercises`	$151.98K	USD	2 Qtrs
Proceeds from exercise of warrants, net	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	$28.52K	USD	2 Qtrs
Proceeds from exercise of stock options, net	`ProceedsFromStockOptionsExercised`	$2.50M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$41.22M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$43.87M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$28.52K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$40.41M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-9.01M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$53.41M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$30.36M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$39.37M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$30.36M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$39.37M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$53.41M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.00M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	-	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Issuance of 64,699 shares of common stock in exchange for the cashless exercise of warrants to purchase 126,433 shares of common stock for the six months ended June 30, 2014. Issuance of 399,629 shares of common stock in exchange for the cashless exercise of warrants to purchase 505,661 shares of common stock for the six months ended June 30, 2013.	`StockIssued1`	$323.49K	USD	2 Qtrs
Issuance of 64,699 shares of common stock in exchange for the cashless exercise of warrants to purchase 126,433 shares of common stock for the six months ended June 30, 2014. Issuance of 399,629 shares of common stock in exchange for the cashless exercise of warrants to purchase 505,661 shares of common stock for the six months ended June 30, 2013.	`StockIssued1`	$2.15M	USD	2 Qtrs

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$49.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.80M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.37M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	12.24M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	12.35M	shares	Point-in-time
Stock compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.27M	USD	2 Qtrs
Stock compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.41M	USD	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueOther`	$187.98K	USD	Annual
Exercise of warrants (in Shares)	`StockIssuedDuringPeriodSharesOther`	64,699.00	shares	2 Qtrs
Exercise of warrants (in Shares)	`StockIssuedDuringPeriodSharesOther`	399,629.00	shares	2 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$28.52K	USD	2 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.51M	USD	Annual
Exercise of stock options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	381,718.00	shares	2 Qtrs
Exercise of stock options (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	4,000.00	shares	2 Qtrs
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$1.72M	USD	Annual
Issuance of restricted stock	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$514.36K	USD	2 Qtrs
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$41.22M	USD	Annual
Issuance of common stock, net of issuance costs (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	1.37M	shares	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.75M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.07M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-15.18M	USD	Annual
Net loss	`NetIncomeLoss`	$-4.70M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.25M	USD	2 Qtrs
Balance	`StockholdersEquity`	$49.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$38.80M	USD	Point-in-time
Balance	`StockholdersEquity`	$14.37M	USD	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	12.24M	shares	Point-in-time
Balance (in Shares)	`CommonStockSharesOutstanding`	12.35M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.